A point-of-care device for diagnosis and management of pulmonary diseases
A point-of-care device for diagnosis and management of pulmonary diseases
批准号:
1804416
负责人:
Stefan Bossmann
金额:
$32.5万
依托单位:
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-05-01 至 2021-04-30
中文摘要
肺癌是癌症相关死亡的最常见原因。发烧或疲劳等症状是非特异性的,而其他指标则是许多其他疾病的典型症状。开发一种可靠的技术,在尽可能早的阶段发现肺癌,对成功的结果至关重要。几种相互竞争的技术证明了它们诊断中晚期肺癌的能力,但未能发现早期癌症,这显著降低了它们的实用性。该项目将合成一组与早期肺癌有关的新型光学生物传感器和指示器。这种新的非侵入性、成本效益和可靠的筛查工具的开发将对整个肺癌预防领域产生革命性的影响。该团队将通过专注于一组生物标志物(基质金属蛋白酶和组织蛋白)来实现技术原理证明,这些生物标志物已被证明成功地检测到了第一阶段非小细胞肺癌(NSCLC),这是最常见的肺癌形式。将开发一种集成的微流控设备来处理一种新型的纳米生物传感器,该传感器旨在检测大量的酶。建议的设备将检测到的生物标志物面板将首先基于从动物模型收集的样本进行优化,然后再基于从人类患者中收集的样本进行优化。该奖项反映了NSF的法定使命,并通过使用基金会的智力优势和更广泛的影响审查标准进行评估,被认为值得支持。
英文摘要
Lung cancer is the most common cause of cancer-related death. Symptoms, such as fever or fatigue, are unspecific while other indicators are typical of many other diseases. Development of a reliable technique that detects lung cancer at the earliest possible stage, is critical for successful outcomes. Several competing techniques demonstrated their ability to diagnose intermediate and late stage lung cancer, but failed to detect early stage cancer which significantly decreases their utility. This project will synthesize a set of novel optical biosensors and indicators that have been implicated in early stage lung cancer. The development of this novel non-invasive, cost effective, and reliable screening tool would be transformative for the whole field of lung cancer prevention.The team will achieve technical proof-of-principle by focusing on a set of biomarkers (matrix metalloproteinases and cathepsins) that have been shown to be successful in detecting stage 1 non-small-cell lung cancer (NSCLC), the most common form of lung cancer. An integrated microfluidic device will be developed to handle a new class of nano-biosensors designed to detect a large number of enzymes. The panel of biomarkers that will be detected by the proposed device will be optimized based on samples collected from animal models first, and human patients later.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteriaThis award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Early detection of non-small cell lung cancer in liquid biopsies by ultrasensitive protease activity analysis
通过超灵敏蛋白酶活性分析在液体活检中早期检测非小细胞肺癌
DOI:
10.20517/2394-4722.2020.45
发表时间:
2020
期刊:
Journal of Cancer Metastasis and Treatment
影响因子:
--
作者:
[Udukala, Dinusha N., Wendel, Sebastian O., Wang, Hongwang, Yapa, Asanka S., Covarrubias-Zambrano, Obdulia, Janik, Katharine, Gadbury, Gary, Troyer, Deryl L., Bossmann, Stefan H.]
通讯作者:
Bossmann, Stefan H.
EAGER: A Microfluidic Device for Studying Environment-Triggered Migration of Glioblastoma Cells
-
批准号:2129352
-
项目类别:Standard Grant
-
资助金额:$30.0万
-
财政年份:2021
-
负责人:Stefan Bossmann
-
依托单位:
EAGER: Engineering Optical Nanobiosensors for Detection of Coronavirus Proteases
-
批准号:2125030
-
项目类别:Standard Grant
-
资助金额:$30.0万
-
财政年份:2021
-
负责人:Stefan Bossmann
-
依托单位:
EFRI CEE: Opening the Gates of Apoptosis in Cancer
-
批准号:2129617
-
项目类别:Standard Grant
-
资助金额:$200.0万
-
财政年份:2021
-
负责人:Stefan Bossmann
-
依托单位:
EFRI CEE: Opening the Gates of Apoptosis in Cancer
-
批准号:1933321
-
项目类别:Standard Grant
-
资助金额:$200.0万
-
财政年份:2020
-
负责人:Stefan Bossmann
-
依托单位:
EAGER: Engineering Optical Nanobiosensors for Detection of Coronavirus Proteases
-
批准号:2032751
-
项目类别:Standard Grant
-
资助金额:$30.0万
-
财政年份:2020
-
负责人:Stefan Bossmann
-
依托单位:
EAGER: A Microfluidic Device for Studying Environment-Triggered Migration of Glioblastoma Cells
-
批准号:1940790
-
项目类别:Standard Grant
-
资助金额:$30.0万
-
财政年份:2019
-
负责人:Stefan Bossmann
-
依托单位:
EAGER: Design and Validation of a Point-of-Care Device To Detect Biomarkers of Pain
-
批准号:1842670
-
项目类别:Standard Grant
-
资助金额:$30.0万
-
财政年份:2018
-
负责人:Stefan Bossmann
-
依托单位:
EAGER: Integrating Optical Fiber Bridges in Microfluidic Devices for Ultrasensitive Analysis of Biomarkers in Single Cells
-
批准号:1656968
-
项目类别:Continuing Grant
-
资助金额:$22.0万
-
财政年份:2016
-
负责人:Stefan Bossmann
-
依托单位:
MRI: Development of an Integrated Image-guided Thermal Therapy Platform
-
批准号:1337438
-
项目类别:Standard Grant
-
资助金额:$120.16万
-
财政年份:2013
-
负责人:Stefan Bossmann
-
依托单位:
Extending the Luminescence Lifetime in Breast Cancer Diagnostics
-
批准号:1159966
-
项目类别:Standard Grant
-
资助金额:$30.46万
-
财政年份:2012
-
负责人:Stefan Bossmann
-
依托单位:
INSPIRE: Neutrophil Delivery of Apoptosis-Inducing Anticancer Drugs
-
批准号:1242765
-
项目类别:Standard Grant
-
资助金额:$60.0万
-
财政年份:2012
-
负责人:Stefan Bossmann
-
依托单位:
Renilla Transfected Stem Cells as Light Source for In-Situ Photodynamic Therapy of Cancer
-
批准号:0933701
-
项目类别:Standard Grant
-
资助金额:$60.97万
-
财政年份:2010
-
负责人:Stefan Bossmann
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于CARE解码框架的跨范式肌电无声语音识别新方法
-
批准号:2026JJ70025
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:谭欣
-
依托单位:
CarE06介导朱砂叶螨对甲氰菊酯对映体代谢抗性形成差异机制
-
批准号:CSTB2023NSCQ-MSX0916
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2023
-
负责人:张平
-
依托单位:
棉铃虫羧酸酯酶CarE001G在杀虫剂代谢和抗性中的作用及机制
-
批准号:U1903111
-
项目类别:联合基金项目
-
资助金额:57万元
-
批准年份:2019
-
负责人:李永强
-
依托单位:
棉铃虫羧酸酯酶CarE001C定向进化及突变酶的结构与功能研究
-
批准号:31201517
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:李永强
-
依托单位:
完善城镇居民基本医疗保险的"基本医疗服务包"研究
-
批准号:70873131
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2008
-
负责人:鱼敏
-
依托单位: